跳至主要内容
临床试验/NCT07482215
NCT07482215尚未招募不适用

Prevalence and Molecular Identification of Human Schistosomiasis With Assessment of Associated Epidemiological Risk Factors in Assiut Governorate, Egypt

Assiut University0 个研究点目标入组 359 人开始时间: 2026年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
359
主要终点
prevalence of human schistosomiasis in the study participants

研究概览

简要总结

Schistosomiasis remains one of the most important parasitic diseases of public health concern, particularly in developing countries including Egypt. It is caused by a trematode worm (blood flukes) of the genus Schistosoma

详细描述

Schistosomiasis has been diagnosed in Egypt since pharaonic times (3200 B.C.) by recovering Schistosome eggs and antigens in ancient mummies.In Egypt, Schistosoma mansoni and Schistosoma haematobium have historically been highly endemic, with widespread distribution along the Nile Delta and Valley.(4) Schistosoma haematobium is responsible for urogenital schistosomiasis, with hematuria as its primary manifestation, while Schistosoma mansoni, the prevalent species in Egypt, is causing intestinal schistosomiasis with liver-related sequelae

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients aged ≥ 5 years of both sexes attending Assiut Governorate hospitals during the study period.
  • Patients clinically suspected of having schistosomiasis (urinary and/or intestinal) or referred for parasitological examination.
  • Individuals (or guardians, in case of minors) who provide written informed consent.
  • Patients willing to provide the required biological samples (urine and/or stool).

排除标准

  • Patients Received praziquantel within the last 3 months before sample collection
  • Patients with incomplete clinical or epidemiological data.
  • Patients refusing participation or sample collection.
  • Improperly collected, contaminated, or insufficient samples.
  • Patients suffering from severe comorbid conditions that may interfere with the interpretation of results (e.g., advanced hepatic or renal failure).
  • children with congenital urinary or intestinal anomalies.

研究组 & 干预措施

Schistosoma haematobium

Urine filtration technique (10 ml urine) for diagnosis

干预措施: Molecular phylogenetic and haplotype analysis (Diagnostic Test)

Schistosoma mansoni

Direct wet mount and Kato-Katz thick smear technique (stool) for diagnosis

干预措施: Molecular phylogenetic and haplotype analysis (Diagnostic Test)

结局指标

主要结局

prevalence of human schistosomiasis in the study participants

时间窗: 24 hours

using conventional microscopic examination

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Intesar Heshmat Yousef

Principial investigator

Assiut University

相似试验